Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.60
+0.01500.95%
Volume:711.76K
Turnover:1.11M
Market Cap:110.20M
PE:-0.88
High:1.62
Open:1.59
Low:1.53
Close:1.58
52wk High:2.98
52wk Low:1.30
Shares:69.09M
Float Shares:66.44M
Volume Ratio:1.15
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8117
EPS(LYR):-1.8117
ROE:-183.47%
ROA:-57.88%
PB:4.57
PE(LYR):-0.88

Loading ...

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

TIPRANKS
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 21

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Inovio’s Earnings Call: INO-3107 Drives 2026 Focus

TIPRANKS
·
Mar 18

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 17

Inovio Pharmaceuticals CEO and CFO face securities class action as control person defendants

Reuters
·
Mar 17

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 14

Piper Sandler Sticks to Its Buy Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
Mar 13

Inovio Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 13

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 12

Inovio Pharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Mar 11

Inovio Pharmaceuticals Inc. published an update to their financial calendar

Reuters
·
Mar 06

Rosen Law Firm Urges Inovio Investors to Act Before April 7 Lead Plaintiff Deadline

Reuters
·
Mar 05

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 05

Inovio Faces Securities Class Action Lawsuit Over FDA Review Timeline Disclosure

Reuters
·
Mar 04

Akeso, INOVIO team up to test cadonilimab plus INO-5412 in GBM trial

Reuters
·
Mar 04

Inovio, Akeso announce clinical collaboration

TIPRANKS
·
Mar 04

BRIEF-Inovio And Akeso Announce Clinical Collaboration To Advance Novel Combination Therapy For Glioblastoma (Gbm)

Reuters
·
Mar 04

Inovio and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

THOMSON REUTERS
·
Mar 04

Inovio - Dosing in Combination Therapy Trial Expected to Begin in H2 2026

THOMSON REUTERS
·
Mar 04